{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T01:35:59Z","timestamp":1769045759610,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470855"],"award-info":[{"award-number":["82470855"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270858"],"award-info":[{"award-number":["82270858"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515010811"],"award-info":[{"award-number":["2024A1515010811"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515012925"],"award-info":[{"award-number":["2024A1515012925"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04492-5","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T10:18:34Z","timestamp":1768990714000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["High prevalence of primary aldosteronism and its impact on diabetic kidney disease in type 2 diabetes mellitus: A retrospective cohort study"],"prefix":"10.1007","volume":"91","author":[{"given":"Xiaoqin","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaochun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nannan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanmei","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qijian","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minghai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feifei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linlin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinzhao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaoming","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiping","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"issue":"5","key":"4492_CR1","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"F FUNDER J W, CAREY R M, MANTERO","year":"2016","unstructured":"F. FUNDER J W, CAREY R M, MANTERO et al., The management of primary aldosteronism: case Detection, Diagnosis, and treatment: an endocrine society clinical practice guideline [J]. J. Clin. Endocrinol. Metab. 101(5), 1889\u20131916 (2016)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"4492_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","volume":"6","author":"S MONTICONE","year":"2018","unstructured":"S. MONTICONE, C. D\u2019ASCENZO F, MORETTI et al., Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis [J]. Lancet Diabetes Endocrinol. 6(1), 41\u201350 (2018)","journal-title":"Lancet Diabetes Endocrinol."},{"key":"4492_CR3","first-page":"100085","volume":"7","author":"F BRAGG","year":"2021","unstructured":"F. BRAGG, J. HALSEY, Y. GUO et al., Blood pressure and cardiovascular diseases in Chinese adults with type 2 diabetes: A prospective cohort study [J]. Lancet Reg. Health West. Pac. 7, 100085 (2021)","journal-title":"Lancet Reg. Health West. Pac."},{"key":"4492_CR4","doi-asserted-by":"crossref","unstructured":"T. NAKAMURA, S. GIRERD, F. JAISSER et al., Nonepithelial mineralocorticoid receptor activation as a determinant of kidney disease [J]. Kidney Int Suppl (2011), 2022, 12(1): 12\u2009\u2013\u20098","DOI":"10.1016\/j.kisu.2021.11.004"},{"issue":"38","key":"4492_CR5","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1093\/eurheartj\/ehac352","volume":"43","author":"A VERMA","year":"2022","unstructured":"A. VERMA, A. VAIDYA, S. SUBUDHI et al., Aldosterone in chronic kidney disease and renal outcomes [J]. Eur. Heart J. 43(38), 3781\u20133791 (2022)","journal-title":"Eur. Heart J."},{"issue":"1","key":"4492_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12020-022-03168-8","volume":"79","author":"M MOUSTAKI","year":"2023","unstructured":"M. MOUSTAKI, PASCHOU S A, VAKALI E C et al., Secondary diabetes mellitus due to primary aldosteronism [J]. Endocrine. 79(1), 17\u201330 (2023)","journal-title":"Endocrine"},{"issue":"6","key":"4492_CR7","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1210\/jc.2012-3934","volume":"98","author":"E FISCHER","year":"2013","unstructured":"E. FISCHER, C. ADOLF, Aldosterone excess impairs first phase insulin secretion in primary aldosteronism [J]. J. Clin. Endocrinol. Metab. 98(6), 2513\u20132520 (2013)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"4492_CR8","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1161\/HYPERTENSIONAHA.119.13922","volume":"75","author":"ADLER G K","year":"2020","unstructured":"ADLER G K, MURRAY G R, TURCU A F et al., Primary aldosteronism decreases insulin secretion and increases insulin clearance in humans [J]. Hypertension. 75(5), 1251\u20131259 (2020)","journal-title":"Hypertension"},{"issue":"1","key":"4492_CR9","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1210\/en.2017-00651","volume":"159","author":"C WU","year":"2018","unstructured":"C. WU, H. ZHANG, J. ZHANG et al., Inflammation and fibrosis in perirenal adipose tissue of patients with Aldosterone-Producing adenoma [J]. Endocrinology. 159(1), 227\u2013237 (2018)","journal-title":"Endocrinology"},{"key":"4492_CR10","doi-asserted-by":"crossref","unstructured":"F. JING, M. MOGI, HORIUCHI M. Role of renin-angiotensin-aldosterone system in adipose tissue dysfunction [J]. Mol Cell Endocrinol, 2013, 378(1\u20132): 23\u2009\u2013\u20098","DOI":"10.1016\/j.mce.2012.03.005"},{"issue":"1","key":"4492_CR11","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s12020-020-02576-y","volume":"72","author":"S GREWAL","year":"2021","unstructured":"S. GREWAL, A. FOSAM, L. CHALK et al., Insulin sensitivity and pancreatic \u03b2-cell function in patients with primary aldosteronism [J]. Endocrine. 72(1), 96\u2013103 (2021)","journal-title":"Endocrine"},{"issue":"1","key":"4492_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/1479164109350556","volume":"7","author":"JJ MUKHERJEE","year":"2010","unstructured":"J.J. MUKHERJEE, KHOO C M, THAI A C et al., Type 2 diabetic patients with resistant hypertension should be screened for primary aldosteronism [J]. Diab Vasc Dis. Res. 7(1), 6\u201313 (2010)","journal-title":"Diab Vasc Dis. Res."},{"issue":"7","key":"4492_CR13","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.2337\/dc07-0031","volume":"30","author":"P UMPIERREZ G E, CANTEY","year":"2007","unstructured":"P. UMPIERREZ G E, CANTEY, Primary aldosteronism in diabetic subjects with resistant hypertension [J]. Diabetes Care. 30(7), 1699\u20131703 (2007)","journal-title":"Diabetes Care"},{"issue":"9","key":"4492_CR14","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.3390\/biomedicines10092308","volume":"10","author":"E TYFOXYLOU","year":"2022","unstructured":"E. TYFOXYLOU, N. VOULGARIS, High prevalence of primary aldosteronism in patients with type 2 diabetes mellitus and hypertension [J]. Biomedicines. 10(9), 2308 (2022)","journal-title":"Biomedicines"},{"issue":"4","key":"4492_CR15","doi-asserted-by":"publisher","first-page":"dgz293","DOI":"10.1210\/clinem\/dgz293","volume":"105","author":"Y HU","year":"2020","unstructured":"Y. HU, J. ZHANG, W. LIU et al., Determining the prevalence of primary aldosteronism in patients with New-Onset type 2 diabetes and hypertension [J]. J. Clin. Endocrinol. Metab. 105(4), dgz293 (2020)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"4492_CR16","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1507\/endocrj.EJ13-0060","volume":"60","author":"K MURASE","year":"2013","unstructured":"K. MURASE, R. NAGAISHI, H. TAKENOSHITA et al., Prevalence and clinical characteristics of primary aldosteronism in Japanese patients with type 2 diabetes mellitus and hypertension [J]. Endocr. J. 60(8), 967\u2013976 (2013)","journal-title":"Endocr. J."},{"issue":"4","key":"4492_CR17","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/cen.14598","volume":"96","author":"SS MEMON","year":"2022","unstructured":"S.S. MEMON, A. LILA, R. BARNABAS et al., Prevalence of primary aldosteronism in type 2 diabetes mellitus and hypertension: A prospective study from Western India [J]. Clin. Endocrinol. (Oxf). 96(4), 539\u2013548 (2022)","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"4","key":"4492_CR18","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1524-6175.2005.05251.x","volume":"8","author":"D JEFIC","year":"2006","unstructured":"D. JEFIC, N. MOHIUDDIN, R. ALSABBAGH et al., The prevalence of primary aldosteronism in diabetic patients [J]. J. Clin. Hypertens. (Greenwich). 8(4), 253\u2013256 (2006)","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"issue":"3","key":"4492_CR19","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/cen.13370","volume":"87","author":"M TANCREDI","year":"2017","unstructured":"M. TANCREDI, G. JOHANNSSON, B. ELIASSON et al., Prevalence of primary aldosteronism among patients with type 2 diabetes [J]. Clin. Endocrinol. (Oxf). 87(3), 233\u2013241 (2017)","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"Supplement1","key":"4492_CR20","first-page":"S175","volume":"45","author":"COMMITTEE A D A P","year":"2021","unstructured":"COMMITTEE A D A P, P. 11, Chronic kidney disease and risk management: standards of medical care in Diabetes\u20142022 [J]. Diabetes Care. 45(Supplement1), S175\u2013S84 (2021)","journal-title":"Diabetes Care"},{"key":"4492_CR21","doi-asserted-by":"publisher","first-page":"n2233","DOI":"10.1136\/bmj.n2233","volume":"375","author":"SKRIVANKOVA V W","year":"2021","unstructured":"SKRIVANKOVA V W, RICHMOND R C, WOOLF B A R et al., Strengthening the reporting of observational studies in epidemiology using Mendelian randomisation (STROBE-MR): explanation and elaboration [J]. Bmj. 375, n2233 (2021)","journal-title":"Bmj"},{"issue":"12","key":"4492_CR22","doi-asserted-by":"publisher","first-page":"e41951","DOI":"10.1097\/MD.0000000000041951","volume":"104","author":"S LIU","year":"2025","unstructured":"S. LIU, J. WAN, Y. YANG et al., Causal association between genetically predicted primary aldosteronism and aortic aneurysm and aortic dissection: A Mendelian randomization study [J]. Medicine. 104(12), e41951 (2025)","journal-title":"Medicine"},{"issue":"1","key":"4492_CR23","doi-asserted-by":"publisher","first-page":"5198","DOI":"10.1038\/s41467-022-32896-8","volume":"13","author":"T LE FLOCH E, COSENTINO","year":"2022","unstructured":"T. LE FLOCH E, COSENTINO, K. LARSEN C et al., Identification of risk loci for primary aldosteronism in genome-wide association studies [J]. Nat. Commun. 13(1), 5198 (2022)","journal-title":"Nat. Commun."},{"issue":"14","key":"4492_CR24","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1161\/CIRCULATIONAHA.122.062349","volume":"147","author":"T NAITO","year":"2023","unstructured":"T. NAITO, K. INOUE, K. SONEHARA et al., Genetic risk of primary aldosteronism and its contribution to hypertension: A Cross-Ancestry Meta-Analysis of Genome-Wide association studies [J]. Circulation. 147(14), 1097\u20131109 (2023)","journal-title":"Circulation"},{"issue":"15","key":"4492_CR25","doi-asserted-by":"publisher","first-page":"e034180","DOI":"10.1161\/JAHA.123.034180","volume":"13","author":"K INOUE","year":"2024","unstructured":"K. INOUE, T. NAITO, R. FUJI et al., Primary aldosteronism and risk of cardiovascular outcomes: Genome-Wide association and Mendelian randomization study [J]. J. Am. Heart Assoc. 13(15), e034180 (2024)","journal-title":"J. Am. Heart Assoc."},{"issue":"7944","key":"4492_CR26","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"J KURKI M I, KARJALAINEN","year":"2023","unstructured":"J. KURKI M I, KARJALAINEN, P. PALTA et al., FinnGen provides genetic insights from a well-phenotyped isolated population [J]. Nature. 613(7944), 508\u2013518 (2023)","journal-title":"Nature"},{"issue":"8","key":"4492_CR27","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1161\/CIRCULATIONAHA.118.033597","volume":"138","author":"JB BYRD","year":"2018","unstructured":"J.B. BYRD, R.J. TURCU A F, AUCHUS, Primary aldosteronism: practical approach to diagnosis and management [J]. Circulation. 138(8), 823\u2013835 (2018)","journal-title":"Circulation"},{"issue":"2","key":"4492_CR28","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1210\/er.2007-0030","volume":"29","author":"JM CONNELL","year":"2008","unstructured":"J.M. CONNELL, MACKENZIE S M, FREEL E M et al., A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function [J]. Endocr. Rev. 29(2), 133\u2013154 (2008)","journal-title":"Endocr. Rev."},{"issue":"1","key":"4492_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12020-022-03084-x","volume":"77","author":"J ARIENS","year":"2022","unstructured":"J. ARIENS, J. HORVATH A R, YANG et al., Performance of the aldosterone-to-renin ratio as a screening test for primary aldosteronism in primary care [J]. Endocrine. 77(1), 11\u201320 (2022)","journal-title":"Endocrine"},{"issue":"9","key":"4492_CR30","first-page":"2081","volume":"13","author":"P. POLENUS","year":"2025","unstructured":"P. POLENUS, A. \u0110URAN, S. \u0160.T.A.M.B.U.K, KARANOVI\u0107, Aldosterone Chronic Kidney Disease [J] Biomedicines. 13(9), 2081 (2025)","journal-title":"Aldosterone Chronic Kidney Disease [J] Biomedicines"},{"issue":"1\u20132","key":"4492_CR31","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1159\/000528783","volume":"54","author":"W MENDE C","year":"2023","unstructured":"W. MENDE C, R. SAMARAKOON, P.J. HIGGINS, Mineralocorticoid receptor-Associated mechanisms in diabetic kidney disease and clinical significance of mineralocorticoid receptor antagonists [J]. Am. J. Nephrol. 54(1\u20132), 50\u201361 (2023)","journal-title":"Am. J. Nephrol."},{"issue":"9","key":"4492_CR32","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1042\/CS20140432","volume":"128","author":"AS BREM","year":"2015","unstructured":"A.S. BREM, R. GONG, Therapeutic targeting of aldosterone: a novel approach to the treatment of glomerular disease [J]. Clin. Sci. (Lond). 128(9), 527\u2013535 (2015)","journal-title":"Clin. Sci. (Lond)"},{"issue":"1","key":"4492_CR33","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.kint.2018.08.024","volume":"95","author":"MJ BUTLER","year":"2019","unstructured":"M.J. BUTLER, R. RAMNATH, H. KADOYA et al., Aldosterone induces albuminuria via matrix metalloproteinase-dependent damage of the endothelial glycocalyx [J]. Kidney Int. 95(1), 94\u2013107 (2019)","journal-title":"Kidney Int."},{"issue":"9","key":"4492_CR34","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1001\/jama.2015.10081","volume":"314","author":"GL BAKRIS","year":"2015","unstructured":"G.L. BAKRIS, R. AGARWAL, J.C. CHAN et al., Effect of finerenone on albuminuria in patients with diabetic nephropathy: A randomized clinical trial [J]. Jama. 314(9), 884\u2013894 (2015)","journal-title":"Jama"},{"issue":"23","key":"4492_CR35","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","volume":"383","author":"GL BAKRIS","year":"2020","unstructured":"G.L. BAKRIS, R. AGARWAL, S.D. ANKER et al., Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes [J]. N Engl. J. Med. 383(23), 2219\u20132229 (2020)","journal-title":"N Engl. J. Med."},{"issue":"2","key":"4492_CR36","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/jdi.13332","volume":"12","author":"S KATSURAGAWA","year":"2021","unstructured":"S. KATSURAGAWA, Y. TSURUTANI, T. TAKIGUCHI et al., Impact of primary aldosteronism on renal function in patients with type 2 diabetes [J]. J. Diabetes Investig. 12(2), 217\u2013225 (2021)","journal-title":"J. Diabetes Investig"},{"issue":"7","key":"4492_CR37","doi-asserted-by":"publisher","first-page":"e030142","DOI":"10.1161\/JAHA.123.030142","volume":"13","author":"JM BROWN","year":"2024","unstructured":"J.M. BROWN, Adverse effects of aldosterone: beyond blood pressure [J]. J. Am. Heart Assoc. 13(7), e030142 (2024)","journal-title":"J. Am. Heart Assoc."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04492-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04492-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04492-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T10:18:37Z","timestamp":1768990717000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04492-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4492"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04492-5","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"18 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol (NFEC-2021-049) was approved by Nanfang Hospital Ethics Committee in accordance with Declaration of Helsinki. All participants provided written informed consent. GWAS data were obtained from public repositories with original ethical approvals; no additional review was required per institutional policy.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"See the additional data file.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Supplementary Information"}}],"article-number":"47"}}